Stock Earnings

Question 1

Quels sont les états financiers clés de Austar Lifesciences Ltd ?

Accepted Answer

Selon le dernier état financier (Form-10K), Austar Lifesciences Ltd a un total d'actifs de $2,083, un bénéfice net profit de $16

Question 2

Quels sont les ratios financiers clés pour AULSF ?

Accepted Answer

Le ratio de liquidité de Austar Lifesciences Ltd est 1.61, la marge nette est 1.06, les ventes par action sont de $2.92.

Question 3

Comment les revenus de Austar Lifesciences Ltd sont-ils répartis par segment ou géographie ?

Accepted Answer

Austar Lifesciences Ltd largest revenue segment is Integrated Process and Packaging Equipment & Systems, at a revenue of 710,388,913 in the most earnings release.For geography, China is the primary market for Austar Lifesciences Ltd, at a revenue of 1,445,798,461.

Question 4

Austar Lifesciences Ltd est-elle rentable ?

Accepted Answer

yes, selon les derniers états financiers, Austar Lifesciences Ltd a un bénéfice net profit de $16

Question 5

Austar Lifesciences Ltd a-t-elle des passifs ?

Accepted Answer

yes, Austar Lifesciences Ltd a un passif de 1,292

Question 6

Combien d'actions en circulation Austar Lifesciences Ltd a-t-elle ?

Accepted Answer

Austar Lifesciences Ltd a un total d'actions en circulation de 512.58

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1,461	1,500	1,763	2,156	2,015	1,295
Revenue Growth (YoY)	-3%	-15%	-18%	7%	56%	23%
Cost of Revenue	1,166	1,199	1,427	1,668	1,536	972
Gross Profit	294	301	336	488	479	323
Selling, General & Admin	238	233	327	299	300	255
Research & Development	46	53	55	70	65	48
Operating Expenses	256	262	377	366	361	296
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	42	21	-34	119	319	41
Income Tax Expense	9	7	0	18	46	9
Net Income	35	16	-113	87	277	33
Net Income Growth	-152%	-113.99%	-229.99%	-69%	739%	313%
Shares Outstanding (Diluted)	512.58	512.58	512.58	512.58	512.58	512.58
Shares Change (YoY)	0%	0%	0%	0%	0%	0%
EPS (Diluted)	0.06	0.03	-0.22	0.17	0.54	0.06
EPS Growth	-153%	-113.99%	-229%	-69%	737%	309%
Free Cash Flow	--	78	-131	-155	-204	25
Free Cash Flow Per Share	--	0.15	-0.25	-0.3	-0.39	0.04
Gross Margin	20.12%	20.06%	19.05%	22.63%	23.77%	24.94%
Operating Margin	2.53%	2.53%	-2.32%	5.65%	5.8%	2%
Profit Margin	2.39%	1.06%	-6.4%	4.03%	13.74%	2.54%
Free Cash Flow Margin	--	5.2%	-7.43%	-7.18%	-10.12%	1.93%
EBITDA	--	91	4	161	148	57
EBITDA Margin	--	6.06%	0.22%	7.46%	7.34%	4.4%
D&A For EBITDA	--	53	45	39	31	31
EBIT	37	38	-41	122	117	26
EBIT Margin	2.53%	2.53%	-2.32%	5.65%	5.8%	2%
Effective Tax Rate	21.42%	33.33%	0%	15.12%	14.42%	21.95%

Austar Lifesciences Ltd (AULSF) Price

AULSF Stock Price Chart

AULSF Income

Follow-Up Questions